RBC Capital reiterates Sector Perform rating on Regeneron Pharmaceuticals, $737 price target

RBC Capital reiterated their Sector Perform rating on Regeneron Pharmaceuticals's stock with a price target of $737.00.The price target implies a downside of 2.0% from the Sep 28 close of $752.25.Key takeaways from the analyst noteMarket Uncertainty and Pipeline Concerns: Regeneron faces challenges…